TerrAscend (TSNDF) Total Current Liabilities (2021 - 2026)
TerrAscend's (TSNDF) quarterly Total Current Liabilities came in at $67.7 million in Q1 2026, down 12.43% year-on-year from $77.3 million in Q1 2025, and down 15.33% on a QoQ basis from $79.9 million in Q4 2025.
TerrAscend (TSNDF) Total Current Liabilities (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Total Current Liabilities data on file, last reported at $67.7 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 12.43% year-over-year to $67.7 million in Q1 2026; TTM through Mar 2026 was $67.7 million, a 12.43% decrease from a year earlier, with the FY2025 full-year figure at $79.9 million, down 12.21% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $67.7 million, down from $79.9 million in the prior quarter.
- Over the last five years, Total Current Liabilities for TSNDF reached as high as $207.0 million in Q4 2023 and fell as low as $67.7 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $122.4 million across 5 years, with a median of $133.5 million in 2023.
- Across the five-year window, Total Current Liabilities jumped 108.36% in 2022 and plunged 61.18% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $137.9 million in 2022, then soared by 50.1% to $207.0 million in 2023, then sank by 56.01% to $91.0 million in 2024, then retreated by 12.21% to $79.9 million in 2025, then slipped by 15.33% to $67.7 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $67.7 million in Q1 2026, $79.9 million in Q4 2025, and $76.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 67.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.68 Mn |
| Dec 31, 2025 | 79.93 Mn |
| Sep 30, 2025 | 76.31 Mn |
| Jun 30, 2025 | 91.66 Mn |
| Mar 31, 2025 | 77.29 Mn |
| Dec 31, 2024 | 91.05 Mn |
| Sep 30, 2024 | 78.46 Mn |
| Jun 30, 2024 | 77.46 Mn |
| Mar 31, 2024 | 199.12 Mn |
| Dec 31, 2023 | 207.00 Mn |
| Sep 30, 2023 | 146.38 Mn |
| Jun 30, 2023 | 133.49 Mn |
| Mar 31, 2023 | 156.07 Mn |
| Dec 31, 2022 | 137.91 Mn |
| Sep 30, 2022 | 172.34 Mn |
| Jun 30, 2022 | 140.40 Mn |
| Mar 31, 2022 | 148.27 Mn |
| Dec 31, 2021 | 66.19 Mn |